Oncology Biosimilars: A Primer for Clinicians

On-demand Webcast with Nathan Pennell, MD, PhD, and Laura Tafe, MD, discussing biomarker testing and personalized therapy in lung cancer, from Clinical Care Options (CCO)

Nathan Pennell, MD, PhD Laura J. Tafe, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ ABIM MOC: maximum of 1.0 Medical Knowledge MOC point(s) ABPath MOC: maximum of 1.0 Lifelong Learning MOC point Released: January 15, 2021 Expired: January 14, 2022

The Why and Who: Newly Available and Emerging Biomarkers for Lung Cancer (25 mins)

The How: Evidence-Based Testing Strategies to Detect Appropriate Gene Alterations (39 mins)

CCO Conference Coverage of ASCO GI 2021 with downloadable slides and expert commentary of clinically relevant studies

Axel Grothey, MD Manish A. Shah, MD Released: January 14, 2021

Enter characteristics of your patient with NSCLC into this online tool from Clinical Care Options to see treatment recommendations from 5 experts

Matthew Gubens, MD, MS Wade T. Iams, MD, MSCI Zofia Piotrowska, MD, MHS Karen L. Reckamp, MD, MS H. Jack West, MD Released: January 12, 2021

Downloadable slides with notes from pharmacist and nursing experts on maintenance avelumab, enfortumab vedotin and erdafitinib for urothelial carcinoma, from CCO

Kinjal Patel, PharmD, BCOP Susan Roethke, CRNP, MSN, AOCN, ANP-BC Released: January 11, 2021